Fredun Pharmaceuticals Ltd (FREDUN) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Fredun Pharmaceuticals Ltd stock ₹531, price ₹1,574, that is 66.2% below the price, quality 34 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Fredun Pharmaceuticals Ltd
FREDUN · BSEFar too expensive (fair value 66% below the price) and weak company.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range ₹124.63 – ₹2,690 · fair‑value band ₹348.23 – ₹713.93 · the ₹1,574 price screens above the ₹531.08 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether Fredun Pharmaceuticals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, and other healthcare products in India, Africa, Southeast Asia, CIS countries, and Latin America.
Show moreShow less
The company offers allopathic formulations, including analgesics/NSAID, antacid/antiulcer, anthelmintic, anti-bacterial, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, antacid, anthelmintic, antibacterial, analgesics, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, anticoagulants, anticonvulsants, antidiarrhoeal, antidepressant, antifungal, antihistamines/antiallergic, antihypertensives, antiviral, bone modulating drugs, bronchodilators and anti-asthma drugs, calcium tablets, cardiovascular, diuretic, impotence drugs, laxative, and appetite stimulant with multivitamins.
It provides surgical products, such as IV fluids and cannula, disposable syringes, infusion sets, surgical gloves and cottons, and personal healthcare products; APIs; direct compressible granules; pellets; animal healthcare products; aqua products; and niche products.
The company was incorporated in 1987 and is headquartered in Mumbai, India.
Stock analysis
Fredun Pharmaceuticals Ltd (FREDUN) currently trades at ₹1,574, while our model-based Fair Value estimate is ₹531.08, 66% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹837.50 per share, and 0 of the 14 models we run sit above the ₹1,574 price.
Bear case: the Asset-Based group reads lowest at ₹80.62, and 14 of the 14 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹348.23 (bear) to ₹713.93 (bull), the price of ₹1,574 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 34/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Fredun Pharmaceuticals Ltd reported revenue of ₹6.3B in FY2025 versus ₹2.2B in FY2021, a compound +30.0%/yr. Reported net income was ₹326M in FY2025, compounding +50.6%/yr from FY2021.
Key figures
Market cap ₹27.3B (≈ $292M) Micro · P/E ratio 57.2 · P/S ratio 3.67 · EPS (TTM) ₹27.53 · Net margin 5.2% · Return on equity 15.6% · Return on assets (EBIT) 10.3% (5-year average) · Operating margin 12.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 41 out of 100 (medium confidence).
What moves the price
The share trades about 41% below its 52-week high and 238% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −28% fair-value upside, at −66%, FREDUN screens richer than that median.
Fair Value models
All 14 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
FREDUN screens overvalued: fair value 66% below the price. Compare with Merck KGaA →
Compare Fredun Pharmaceuticals Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 605 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.48 | $113.53 | +36% | vs FREDUN |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.66 | ¥52.43 | +10% | vs FREDUN |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,870 | ₹1,983 | +6% | vs FREDUN |
| Haleon plc HLN | $9.05 | $8.47 | −6% | vs FREDUN |
| Merck KGaA MRK | €150.75 | €108.83 | −28% | vs FREDUN |
| Galderma Group GALD | CHF 187.15 | CHF 112.46 | −40% | vs FREDUN |
| Takeda Pharmaceutical Company TAK | $21.64 | $11.23 | −48% | vs FREDUN |
| Sandoz Group SDZ | CHF 83.00 | CHF 40.91 | −51% | vs FREDUN |
| Teva Pharmaceutical Industries Limited TEVA | $42.62 | $20.74 | −51% | vs FREDUN |
| Divi's Laboratories Limited DIVISLAB | ₹11,150 | ₹1,567 | −86% | vs FREDUN |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Fredun Pharmaceuticals Ltd (FREDUN) overvalued or undervalued?
What is the fair value of FREDUN?
What is the quality score of FREDUN?
What is the price target for Fredun Pharmaceuticals Ltd (FREDUN)?
What is the Fredun Pharmaceuticals Ltd stock forecast for 2026?
What is the revenue of Fredun Pharmaceuticals Ltd (FREDUN)?
What is the intrinsic value of Fredun Pharmaceuticals Ltd (FREDUN)?
Is Fredun Pharmaceuticals Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of FREDUN?
How much is Fredun Pharmaceuticals Ltd worth?
What do the bullish and bearish scenarios say about FREDUN?
What is the P/E ratio of FREDUN?
How solid is the balance sheet of Fredun Pharmaceuticals Ltd (FREDUN)?
How far is FREDUN from its 52-week high?
Which stocks are comparable to Fredun Pharmaceuticals Ltd?
Is Fredun Pharmaceuticals Ltd stock attractive at the current price?
How is the fair value of FREDUN calculated?
Is it still worth investing in stocks now?
What is the share price of Fredun Pharmaceuticals Ltd (FREDUN)?
What should I pay attention to with Fredun Pharmaceuticals Ltd right now?
Key figures of Fredun Pharmaceuticals Ltd
How large is the market capitalisation of Fredun Pharmaceuticals Ltd (FREDUN)?
What is the P/S ratio of Fredun Pharmaceuticals Ltd (FREDUN)?
What are the earnings per share of Fredun Pharmaceuticals Ltd (FREDUN)?
What is the net margin of Fredun Pharmaceuticals Ltd (FREDUN)?
What is the return on equity of Fredun Pharmaceuticals Ltd (FREDUN)?
What is the EBIT return on assets of Fredun Pharmaceuticals Ltd (FREDUN)?
What is the operating margin of Fredun Pharmaceuticals Ltd (FREDUN)?
How fast is revenue growing at Fredun Pharmaceuticals Ltd (FREDUN)?
How fast are earnings growing at Fredun Pharmaceuticals Ltd (FREDUN)?
How much free cash flow does Fredun Pharmaceuticals Ltd (FREDUN) generate?
How much net debt does Fredun Pharmaceuticals Ltd (FREDUN) carry?
Watch Fredun Pharmaceuticals Ltd in the live analysis
One click puts Fredun Pharmaceuticals Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.